Structure of Theaflavin
CAS No.: 4670-05-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Theaflavin, a type of thearubigins, exhibits inhibition of xanthine oxidase enzyme and can scavenge various oxidation radicals with anti-oxidant and anti-tumor activities. It can be purified from the leaves of Camellia sinensis (L.) O. Kuntze.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 4670-05-7 |
Formula : | C29H24O12 |
M.W : | 564.49 |
SMILES Code : | O=C1C(O)=CC([C@@H]2[C@H](O)CC3=C(O2)C=C(O)C=C3O)=CC4=C([C@@H]5[C@H](O)CC6=C(O5)C=C(O)C=C6O)C=C(O)C(O)=C41 |
MDL No. : | MFCD03427500 |
InChI Key : | IPMYMEWFZKHGAX-ZKSIBHASSA-N |
Pubchem ID : | 135403798 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
BMDMs | 50, 100, 200 µM | 1 hour | Theaflavin dose-dependently inhibited NLRP3 inflammasome activation induced by ATP or nigericin, as evidenced by reduced release of caspase-1p10 and mature IL-1β. | Acta Pharmacol Sin. 2023 Oct;44(10):2019-2036. |
J774A.1 cells | 50, 100, 200 µM | 1 hour | Theaflavin dose-dependently inhibited NLRP3 inflammasome activation induced by ATP or nigericin, as evidenced by reduced release of caspase-1p10 and mature IL-1β. | Acta Pharmacol Sin. 2023 Oct;44(10):2019-2036. |
3T3-L1 adipocytes | 100 µM | 10 days | To evaluate the effects of theaflavin-3,3'-digallate on methylmercury-exposed 3T3-L1 adipocytes. Results showed that 100 µM TF-3 partially restored adipocyte morphology and adipokine secretion patterns. | Int J Mol Sci. 2019 Jun 5;20(11):2755 |
3T3-L1 adipocytes | 50 µM | 10 days | To evaluate the effects of theaflavin-3,3'-digallate on methylmercury-exposed 3T3-L1 adipocytes. Results showed that 50 µM TF-3 partially restored adipocyte morphology and adipokine secretion patterns. | Int J Mol Sci. 2019 Jun 5;20(11):2755 |
3T3-L1 adipocytes | 25 µM | 10 days | To evaluate the effects of theaflavin-3,3'-digallate on methylmercury-exposed 3T3-L1 adipocytes. Results showed that 25 µM TF-3 significantly restored adipocyte morphology and adipokine secretion patterns. | Int J Mol Sci. 2019 Jun 5;20(11):2755 |
3T3-L1 adipocytes | 12.5 µM | 10 days | To evaluate the effects of theaflavin-3,3'-digallate on methylmercury-exposed 3T3-L1 adipocytes. Results showed that 12.5 µM TF-3 partially restored adipocyte morphology and adipokine secretion patterns. | Int J Mol Sci. 2019 Jun 5;20(11):2755 |
3T3-L1 adipocytes | 6.25 µM | 10 days | To evaluate the effects of theaflavin-3,3'-digallate on methylmercury-exposed 3T3-L1 adipocytes. Results showed that 6.25 µM TF-3 significantly improved adipocyte morphology and adipokine secretion patterns. | Int J Mol Sci. 2019 Jun 5;20(11):2755 |
3T3-L1 adipocytes | 3.14 µM | 10 days | To evaluate the effects of theaflavin-3,3'-digallate on methylmercury-exposed 3T3-L1 adipocytes. Results showed that 3.14 µM TF-3 partially restored the morphological changes and adipokine secretion patterns induced by methylmercury. | Int J Mol Sci. 2019 Jun 5;20(11):2755 |
HK-2 cells | 20 and 50 μg/ml | 2 hours pretreatment followed by 24 hours | To evaluate the protective effect of theaflavin on COM-induced oxidative stress injury in renal tubular epithelial cells. Results showed that theaflavin significantly enhanced SOD activity, reduced LDH, MDA, and H2O2 levels, decreased intracellular ROS generation, and upregulated SIRT1 expression. | Int J Biol Sci. 2021 Mar 2;17(4):1050-1060 |
Human subcutaneous fat cells (hSCF) | 0.5 to 2 μg/mL (TF and TFDG) | 21 days | To assess the effects of theaflavin on adipocyte differentiation. Results showed that theaflavin (TF) increased intracellular lipid droplet formation at concentrations ranging from 0.5 to 2 μg/mL, while theaflavin-3,3'-digallate (TFDG) inhibited lipid droplet formation. | Int J Mol Sci. 2019 Apr 25;20(8):2034 |
Human subcutaneous fat cells (hSCF) | 1 to 5 μg/mL | 24 and 72 hours | To evaluate the effects of theaflavin on cell proliferation and viability. Results showed that theaflavin increased cell proliferation after 24 h, and no cytotoxicity was observed after 72 h, with a slight increase in cell viability in some cases. | Int J Mol Sci. 2019 Apr 25;20(8):2034 |
A875 melanoma cells | 240 µg/ml (464.7 µM) | 24 hours | To evaluate the effect of theaflavin on another melanoma cell line. Results showed that theaflavin significantly inhibited the viability of A875 cells. | Front Pharmacol. 2020 Aug 31;11:1317 |
HFF-1 skin fibroblasts | 240 µg/ml (464.7 µM) | 24 hours | To evaluate the effect of theaflavin on normal cells. Results showed that theaflavin had little effect on the viability of HFF-1 cells. | Front Pharmacol. 2020 Aug 31;11:1317 |
Human umbilical vein endothelial cells (HUVECs) | 0, 25, 50 µM | 24 hours | To evaluate the protective effect of Theaflavin on TBHP-induced oxidative stress. Results showed that Theaflavin alleviated apoptosis and cell dysfunction and activated the PI3K/AKT/Nrf2 signaling pathway. | Front Bioeng Biotechnol. 2022 Mar 2;10:830574 |
A375 human melanoma cells | 50-400 µg/ml (96.8-744.4 µM) | 24, 48, 72 hours | To evaluate the anti-proliferative and pro-apoptotic effects of theaflavin on melanoma cells. Results showed that theaflavin significantly inhibited the proliferation of A375 cells in a concentration-dependent manner, with IC50 values of 218.9 µg/ml (423.8 µM) at 24 hours and 84.9 µg/ml (164.4 µM) at 72 hours. | Front Pharmacol. 2020 Aug 31;11:1317 |
Porcine nasopharyngeal epithelial cell Nptr | 256 µg/mL (1/2 MIC) | 30 minutes | Evaluate the effect of theaflavin on the adhesion ability of Streptococcus suis SC19, results showed significantly reduced adhesion | Int J Mol Sci. 2023 Apr 18;24(8):7442 |
Porcine nasopharyngeal epithelial cell Nptr | 128 µg/mL (1/4 MIC) | 30 minutes | Evaluate the effect of theaflavin on the adhesion ability of Streptococcus suis SC19, results showed reduced adhesion | Int J Mol Sci. 2023 Apr 18;24(8):7442 |
Porcine nasopharyngeal epithelial cell Nptr | 512 µg/mL | 30 minutes | Evaluate the cytotoxicity of theaflavin on Nptr cells, results showed no cytotoxicity | Int J Mol Sci. 2023 Apr 18;24(8):7442 |
Drosophila intestinal cells | 1 mg/mL and 2.5 mg/mL | Continuous feeding | Theaflavins extend Drosophila lifespan and increase climbing ability | iScience. 2021 Feb 6;24(3):102150 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Larval zebra fishes | A375 xenograft model | Dissolved in culture medium | 0.22, 0.67, 2.0 mg/ml (0.4, 1.3, 3.9 µM) | 24 hours | To evaluate the inhibitory effect of theaflavin on melanoma growth in vivo. Results showed that theaflavin significantly inhibited A375 tumor growth in larval zebra fishes, with an inhibitory rate of 46.4% at 2.0 mg/ml (3.9 μM), outperforming cisplatin. | Front Pharmacol. 2020 Aug 31;11:1317 |
Drosophila melanogaster | W1118 Drosophila | Dietary supplementation | 1 mg/mL and 2.5 mg/mL | Continuous feeding | Theaflavins extend Drosophila lifespan and increase climbing ability | iScience. 2021 Feb 6;24(3):102150 |
Male albino Wistar rats | High fat diet and streptozotocin-induced diabetic rat model | Oral | 100 mg/kg b.w/day | Once daily for 30 days | To evaluate the effect of theaflavin on the activities of key enzymes of carbohydrate metabolism in high fat diet and streptozotocin-induced diabetic rats. The results showed that theaflavin significantly ameliorated plasma glucose, insulin levels, HOMA-IR index, HbA1c, and glycogen content in liver and muscle. Additionally, theaflavin reduced lipid peroxidation markers (TBARS and hydroperoxides) and enhanced the activities of antioxidant enzymes. | Redox Rep. 2019 Dec;24(1):41-50 |
Sprague-Dawley rats | Full-thickness skin wound model | Oral | 20 mg/kg | Once daily until the end of the experiment | To evaluate the promoting effect of Theaflavin on wound healing. Results showed that Theaflavin enhanced vascularization in regenerated tissues and accelerated wound healing. | Front Bioeng Biotechnol. 2022 Mar 2;10:830574 |
C57BL/6J male mice | CaOx nephrocalcinosis mouse model | Gavage | 20, 50, and 100 mg/kg | Once daily for 14 days | To evaluate the protective effect of theaflavin on CaOx-induced kidney oxidative stress injury and crystal deposition. Results showed that theaflavin significantly reduced crystal deposition, alleviated tissue damage and apoptosis, and improved oxidative stress status. | Int J Biol Sci. 2021 Mar 2;17(4):1050-1060 |
C57BL/6J mice | MSU-induced peritonitis model | Oral | 250 mg/kg | Once daily for three consecutive days | Theaflavin significantly attenuated MSU-induced peritonitis in mice, as shown by reduced levels of IL-1β and IL-6 in peritoneal lavage fluids and decreased neutrophil infiltration. | Acta Pharmacol Sin. 2023 Oct;44(10):2019-2036. |
Sprague-Dawley rats | Middle cerebral artery occlusion (MCAO) model | Intravenous injection | 5, 10, and 20 mg/kg | Single administration, lasting 24 hours | Theaflavin significantly protected neurons from cerebral ischemia-reperfusion injury by limiting leukocyte infiltration and expression of ICAM-1, and suppressing upregulation of inflammatory-related prooxidative enzymes (iNOS and COX-2) in ischemic brain via, at least in part, reducing the phosphorylation of STAT-1. | Mediators Inflamm. 2006;2006(5):30490 |
Kun-Ming mice | Streptococcus suis SC19 infection model | Intragastrically | 50 mg/kg | Single administration, observed for 7 days post-infection | Evaluate the protective effect of theaflavin on infected mice, results showed survival rate increased to 40% and clinical symptoms were alleviated | Int J Mol Sci. 2023 Apr 18;24(8):7442 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03194620 | Healthy | Not Applicable | Completed | - | United States, California ... More >> UC Davis Davis, California, United States, 95616 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.77mL 0.35mL 0.18mL |
8.86mL 1.77mL 0.89mL |
17.72mL 3.54mL 1.77mL |
Tags: Theaflavin | Influenza Virus | Endogenous Metabolite | inhibitor | 4670-05-7 |
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL